National and international developments in cancer, health and policy. Produced in collaboration with the Press Association unless otherwise stated.
Two new cancer treatment options have been accepted for use in Scotland for some patients living with breast and kidney cancer.
A new treatment for early stage breast cancer will be made available for certain patients on the NHS in England.
A targeted treatment for advanced ovarian cancer has been approved for use on the NHS in England and will be paid for by the Cancer Drugs Fund.
The Scottish Medicines Consortium (SMC) has made decisions on five new cancer treatments, including a personalised blood cancer immunotherapy.
An immunotherapy treatment for triple negative breast cancer has been provisionally rejected for NHS use in England.